Citation Impact
Citing Papers
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
1992
Signal transduction and regulation in smooth muscle
1994 StandoutNature
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Functional diversity of helper T lymphocytes
1996 StandoutNature
Identification of an Essential Signaling Cascade for Mitogen-activated Protein Kinase Activation by Angiotensin II in Cultured Rat Vascular Smooth Muscle Cells
1996
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
Nucleotide signalling during inflammation
2014 StandoutNature
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.
1996
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Effect of Multiple Prolyl Isomerization Reactions on the Stability and Folding Kinetics of the Notch Ankyrin Domain: Experiment and Theory
2005
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
1995 StandoutNatureNobel
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury
1999
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
1998 StandoutNobel
G Protein-coupled Receptors Mediate Two Functionally Distinct Pathways of Tyrosine Phosphorylation in Rat 1a Fibroblasts
1997 StandoutNobel
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
1994
Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.
1994
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM
1995 StandoutNobel
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential
2000
Kinins mediate the antiproliferative effect of ramipril in rat carotid artery
1992
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
Angiotensin-converting enzyme in non-neoplastic kidney diseases
1999
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
1992
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors
1994
Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
1995
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts
1995
Asparaginyl Hydroxylation of the Notch Ankyrin Repeat Domain by Factor Inhibiting Hypoxia-inducible Factor
2007 StandoutNobel
Ras-dependent Mitogen-activated Protein Kinase Activation by G Protein-coupled Receptors
1997 StandoutNobel
Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
1990
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
1992 Nature
Atherosclerosis — An Inflammatory Disease
1999 Standout
Expression of AT2 receptors in the developing rat fetus.
1991
Serotonin 5-HT1A Receptor-mediated Erk Activation Requires Calcium/Calmodulin-dependent Receptor Endocytosis
1999 StandoutNobel
Isosteric replacement of sulfur with other chalcogens in peptides and proteins
2005
Angiotensin-Converting Enzyme Inhibition Partially Prevents Diabetic Organomegaly
1994
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production
2000
Eosinophils: Biology and Role in Disease
1995
Elastin is an essential determinant of arterial morphogenesis
1998 StandoutNature
Transgenic Mice as a Tool to Study the Renin-Angiotensin System
2001
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta.
1992
Molecular Characterization of the 56-kDa CYP153 from Acinetobacter sp. EB104
2001
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage—foam cell accumulation independently of blood pressure and plasma lipids
1994
Brain angiotensin receptor subtypes in the control of physiological and behavioral responses
1994
Selective Antagonism of the ETA Receptor Reduces Neointimal Hyperplasia After Balloon-Induced Vascular Injury in Pigs
1997
Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with Hypertension
1991
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo
1995
Angiotensin Receptors and Their Therapeutic Implications
1996
Role of Angiotensin II–Regulated Apoptosis Through Distinct AT 1 and AT 2 Receptors in Neointimal Formation
2002
Activation of H2O2 by Chiral Confined Brønsted Acids: A Highly Enantioselective Catalytic Sulfoxidation
2012 StandoutNobel
Pathological Role of Angiotensin II in Severe COVID-19
2020
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Angiotensin Blockade Inhibits Activation of Mitogen-Activated Protein Kinases in Rat Balloon-Injured Artery
1998 StandoutNobel
Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
1990
An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis.
1994
Anti–Monocyte Chemoattractant Protein-1/Monocyte Chemotactic and Activating Factor Antibody Inhibits Neointimal Hyperplasia in Injured Rat Carotid Arteries
1999
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Overexpression of angiotensin AT 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
1997 StandoutNobel
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
Angiotensin II Receptor Antagonist TCV-116 Reduces Graft Coronary Artery Disease and Preserves Graft Status in a Murine Model
1996
Angiotensin actions in the kidney: Renewed insight into the old hormone
1991
Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
1993
Maintaining Biological Activity by Using Triazoles as Disufide Bond Mimetics
2011 StandoutNobel
Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.
1993
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
1993
Effect of NC-1300-0-3 on Healing of Acetic Acid-Induced Gastric Ulcers in Rats
1993
Vascular Gene Transfer of the Human Inducible Nitric Oxide Synthase: Characterization of Activity and Effects on Myointimal Hyperplasia
1996
Pyridoxal Phosphate Enzymes: Mechanistic, Structural, and Evolutionary Considerations
2004
Angiotensin II Type 1 Receptor Blockade Inhibits the Expression of Immediate-Early Genes and Fibronectin in Rat Injured Artery
1995
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
1996
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
1996
CYP153A6, a Soluble P450 Oxygenase Catalyzing Terminal-Alkane Hydroxylation
2006
Interferon-gamma inhibits arterial stenosis after injury.
1991
Genetic Dissection of Complex Traits
1994 StandoutScience
Applications of Catalytic Asymmetric Sulfide Oxidations to the Syntheses of Biologically Active Sulfoxides
2005
Renal injury from angiotensin II-mediated hypertension.
1992
Chemomimetic Biocatalysis: Exploiting the Synthetic Potential of Cofactor-Dependent Enzymes To Create New Catalysts
2015 StandoutNobel
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.
1995
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
In Vivo Evolution of Butane Oxidation by Terminal Alkane Hydroxylases AlkB and CYP153A6
2008 StandoutNobel
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
2000
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
Estrogen Reduces Myointimal Proliferation After Balloon Injury of Rat Carotid Artery
1996
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
1994 Science
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
1997 StandoutNobel
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
1994
Reduced growth, abnormal kidney structure, and type 2 (AT 2 ) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT 1A and AT 1B receptors for angiotensin II
1998 StandoutNobel
The Intima
1995
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
1994
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of Rita Müller being referenced
Ro 18-5364, a potent new inhibitor of the gastric (H+ + K+)-ATPase
1987
Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine 1 1 1Edited by R. Huber
1999
Suppression of the vascular response to injury: The role of angiotensin-converting enzyme inhibitors
1991
Enhanced Leukotriene C<sub>4</sub> Production by Peripheral Eosinophilic Granulocytes from Children with Asthma
1989
The Proliferative Response to Vascular Injury Is Suppressed by Angiotensin-Converting Enzyme Inhibition
1990
Relationship between LTC<sub>4</sub> Generation of Hypodense Eosinophils and Bronchial Hyperreactivity in Asthmatic Children
1990
Kinetic Mechanism and Catalysis of a Native-state Prolyl Isomerization Reaction
2003
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
1989 Science
Role of angiotensin II in injury-induced neointima formation in rats.
1991
SYNTHESES AND BIOLOGICAL ACTIVITIES OF METHOXININE‐ANALOGUES OF THE C‐TERMINAL OCTAPEPTIDE OF CHOLECYSTOKININ‐PANCREOZYMIN
1979
Isolierung von Cytochrom P‐450 und des entsprechenden Reductasesystems aus Acinetobacter calcoaceticus
1983
Purification of cytochrome P-450 from n-hexadecane-grown Acinetobacter calcoaceticus.
1989